Genepoint has surpassed 300 automated sample storage system installations worldwide by October 2025, marking another important milestone in the company's global expansion and continued commitment to advancing biobank automation.
This achievement reflects the growing trust that research institutions, hospitals, pharmaceutical companies, and biobanks place in Genepoint's automated biospecimen storage solutions. Over the past decade, Genepoint has remained committed to delivering reliable, intelligent, and scalable sample storage systems that help customers improve sample security, operational efficiency, and long-term biobank management.
Today, Genepoint's automated sample storage systems are deployed in multiple countries and regions, supporting a wide range of applications including biobanking, clinical research, pharmaceutical R&D, precision medicine, and population health programs.
The milestone of 300 global installations represents more than a number—it demonstrates the confidence customers place in Genepoint's technology, product quality, and long-term service capabilities. As laboratories continue to pursue higher standards of sample integrity, traceability, and automation, Genepoint remains dedicated to providing dependable automated sample storage solutions that protect valuable biospecimens throughout their lifecycle.
Looking ahead, Genepoint will continue to innovate in automated sample management and cryogenic storage technologies, helping laboratories build smarter, safer, and more efficient biobanking infrastructure around the world.
